[{"id":"a7bc29a2-9d83-422b-b210-345c766604ff","acronym":"","url":"https://clinicaltrials.gov/study/NCT03696030","created_at":"2021-01-18T18:06:55.252Z","updated_at":"2025-02-25T16:44:28.884Z","phase":"Phase 1","brief_title":"HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases","source_id_and_acronym":"NCT03696030","lead_sponsor":"City of Hope Medical Center","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 amplification","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MB-103"],"overall_status":"Recruiting","enrollment":" Enrollment 39","initiation":"Initiation: 08/31/2018","start_date":" 08/31/2018","primary_txt":" Primary completion: 03/11/2025","primary_completion_date":" 03/11/2025","study_txt":" Completion: 03/11/2025","study_completion_date":" 03/11/2025","last_update_posted":"2025-02-06"},{"id":"fd9481d6-68fb-48f5-91be-f04325aa1f68","acronym":"","url":"https://clinicaltrials.gov/study/NCT03389230","created_at":"2021-01-18T16:43:38.153Z","updated_at":"2024-07-02T16:35:24.644Z","phase":"Phase 1","brief_title":"Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma","source_id_and_acronym":"NCT03389230","lead_sponsor":"City of Hope Medical Center","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MB-103"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 29","initiation":"Initiation: 08/14/2018","start_date":" 08/14/2018","primary_txt":" Primary completion: 06/14/2024","primary_completion_date":" 06/14/2024","study_txt":" Completion: 06/14/2024","study_completion_date":" 06/14/2024","last_update_posted":"2024-01-03"}]